Esomeprazole and omeprazole may well boost the serum concentrations of benzodiazepines (through CYP2C19 inhibition) leading to increased adverse effects which include drowsiness, although the medical relevance is small in many clients – monitor the individual for adverse effects (e. If affected person can not resume their normal oral medication submit-operatively https://medeusresearchchem.com/product-category/research-chemicals/